Skip to main content

Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · IEX Real-Time Price · USD
18.84 -0.16 (-0.84%)
Dec 3, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012
Revenue
1.054.468.3943.482.544.324.324.41
Revenue Growth
-76.46%-46.80%109.49%15.13%37.00%-41.25%0.09%-2.04%-
Cost of Revenue
000002.473.372.783.04
Gross Profit
1.054.468.3943.480.070.951.541.36
Selling, General & Admin
13.2711.6511.0510.916.7710.257.571.764.23
Research & Development
28.334.7930.4219.6213.6910.350.230.23
Other Operating Expenses
69.8600000-0.1-0.250.93
Operating Expenses
111.4346.4441.4730.5420.4611.257.821.745.39
Operating Income
-110.38-41.98-33.08-26.53-16.99-11.19-6.87-0.2-4.03
Interest Expense / Income
0.510.840.870.380.330.141.021.961.59
Other Expense / Income
-0.17-0.94-1.25-0.4-0.040-1.25-2.161.98
Pretax Income
-110.72-41.87-32.7-26.51-17.27-11.33-6.640-7.6
Net Income
-110.72-41.87-32.7-26.51-17.27-11.33-6.640-7.6
Preferred Dividends
0000.010.05000.290.39
Net Income Common
-110.72-41.87-32.7-26.52-17.32-11.33-6.64-0.29-7.99
Shares Outstanding (Basic)
422100000
Shares Outstanding (Diluted)
422100000
Shares Change
70.27%5.87%53.81%3034.25%13.82%258.53%1028.35%127.37%-
EPS (Basic)
-31.13-20.04-16.50-20.70-423.15-315.30-787.11-2750.37-19459.51
EPS (Diluted)
-31.13-20.04-16.50-20.70-423.15-315.30-787.11-2750.37-19459.51
Free Cash Flow Per Share
-8.38-17.30-13.83-22.15-366.56-195.22-247.13-1318.96-16159.70
Gross Margin
100.00%100.00%100.00%100.00%100.00%2.60%22.08%35.63%30.95%
Operating Margin
-10512.38%-941.02%-394.51%-662.80%-488.55%-440.78%-158.96%-4.56%-91.40%
Profit Margin
-10544.29%-938.65%-389.97%-662.30%-496.81%-446.34%-153.70%--172.52%
Free Cash Flow Margin
-2840.10%-810.13%-325.41%-709.79%-431.55%-276.64%-57.38%-27.18%-143.27%
EBITDA
-109.97-40.75-31.55-25.82-16.61-11-5.472.11-5.87
EBITDA Margin
-10473.14%-913.47%-376.21%-645.04%-477.62%-433.53%-126.69%48.91%-133.13%
EBIT
-110.21-41.04-31.83-26.13-16.95-11.19-5.621.96-6.01
EBIT Margin
-10495.90%-919.93%-379.56%-652.74%-487.43%-440.78%-130.02%45.48%-136.40%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).